Hepatitis B virus (HBV) remains an important cause of acute and chronic liver disease globally and in the United States. An encouraging trend is that the incidence of acute hepatitis B in the United States declined as much as 80% between 1987 and 2004, attributable to effective vaccination programs
Epidemiology of hepatitis B in the United States
โ Scribed by W. Ray Kim
- Publisher
- Current Science Inc.
- Year
- 2007
- Tongue
- English
- Weight
- 705 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1540-3416
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In the United Republic of Tanzania, 457 voluntary blood donors were enrolled in hepatitis B virus (HBV) serological screening; 4.8% (22/457) carried HBsAg, 13.6% (3/22) of whom were HBeAg-positive. The mean age among HBeAg-negative carriers was 31 years. HBV DNA was detectable in 81.8% (18/22), the
Important innovations, such as hepatitis B immune globulin (HBIG) and lamivudine, have been introduced to the care of patients undergoing liver transplantation (OLT) for viral hepatitis B (HBV) (over the last 15 years). We analyzed survival of OLT recipients with HBV in the United States to examine